Clinical features and disease course of patients with juvenile dermatomyositis
Open Access
- 3 June 2013
- journal article
- research article
- Published by Wiley in International Journal of Rheumatic Diseases
- Vol. 16 (5) , 561-567
Abstract
Objective To describe the clinical features and course of a cohort of patients with juvenile dermatomyositis (JDM) at a tertiary referral pediatric centre in Australia and examine changes in diagnostic and therapeutic approach over time. Methods Retrospective review of patients diagnosed with JDM at the Royal Children's Hospital, Melbourne, between 1989 and 2010. Results Fifty-seven patients were identified. The female : male ratio was 2 : 1 and median age at diagnosis was 7.1 years (2.2–15.3). At diagnosis, 95% had weakness, all had typical rash and 68% had nailfold capillary changes. Calcinosis was not present in any patients at diagnosis and occurred in 18% over time. Creatine kinase, lactate dehydrogenase, aspartate aminotransferase, alanine aminotransferase and aldolase levels were abnormal in 65%, 92%, 88%, 58% and 100%, respectively. Magnetic resonance imaging (MRI) was abnormal in 97% of patients, electomyograph (EMG) in 83% and muscle biopsy in all four patients in whom it was performed. MRI was used in 86% (24/28) of patients diagnosed after 2000. Muscle biopsy was used in four and EMG in no patients over the same period. Treatment used throughout the disease course included oral steroids (93%), high-dose pulse intravenous steroids (82%), methotrexate (63%), intravenous immunoglobulin (32%) and cyclosporin (18%). The disease was monophasic in 46.7% (21/45), polyphasic in 17.7% (8/45) and chronic in 35.5% (16/45). Conclusions Australian patients with JDM have similar characteristics to previously described cohorts. In practice, MRI has replaced the invasive diagnostic tests included in the Bohan and Peter criteria for the diagnosis of JDM. The early use of disease-modifying anti-rheumatic drugs has become the most common treatment approach.Keywords
This publication has 19 references indexed in Scilit:
- Long‐term outcome and prognostic factors of juvenile dermatomyositis: A multinational, multicenter study of 490 patientsArthritis Care & Research, 2009
- Predicting the course of juvenile dermatomyositis: Significance of early clinical and laboratory featuresArthritis & Rheumatism, 2008
- The Juvenile Dermatomyositis National Registry and Repository (UK and Ireland)--clinical characteristics of children recruited within the first 5 yrRheumatology, 2006
- An international consensus survey of the diagnostic criteria for juvenile dermatomyositis (JDM)Rheumatology, 2006
- National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary—Clinical characteristics and disease course of 44 patients with juvenile dermatomyositisAutoimmunity, 2006
- The effectiveness of treating juvenile dermatomyositis with methotrexate and aggressively tapered corticosteroidsArthritis & Rheumatism, 2005
- US incidence of juvenile dermatomyositis, 1995–1998: Results from the National Institute of Arthritis and Musculoskeletal and Skin Diseases RegistryArthritis Care & Research, 2003
- THE INCIDENCE OF JUVENILE DERMATOMYOSITIS: RESULTS FROM A NATION-WIDE STUDYRheumatology, 1995
- Childhood dermatomyositis: Factors predicting functional outcome and development of dystrophic calcificationThe Journal of Pediatrics, 1983
- Polymyositis and DermatomyositisNew England Journal of Medicine, 1975